Shasun Pharmaceuticals Ltd Merged Annually Results

Gross Sales

1,251.95

1,157.65

1,029.66

1,014.91

790.78

Excise Duty

0

0

0

0

0

Net Sales

1,251.95

1,157.65

1,029.66

1,014.91

790.78

Other Operating Income

64.68

55.04

55.11

51.47

43.65

Other Income

20.08

22.94

18.06

40.91

21.96

Total Income

1,336.71

1,235.63

1,102.83

1,107.31

856.41

Total Expenditure

1,207.05

1,111.79

974.33

943.4

762.97

PBIDT

129.66

123.83

128.5

163.91

93.44

Interest

52.53

41.5

25.45

43.7

32.25

PBDT

77.13

82.33

103.05

120.2

61.18

Depreciation

46.96

59.36

52.65

40.56

37.58

Minority Interest Before NP

0

0

0

0

0

Tax

6.33

-7.26

-2.64

-20.93

-3.01

Deferred Tax

0

0

0

0

0

Reported Profit After Tax

23.84

30.23

53.04

100.56

26.62

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

23.76

30.2

53.04

100.56

26.62

Extra-ordinary Items

6.2

0

0

27.12

0

Adjusted Profit After Extra-ordinary item

17.56

30.2

53.04

73.44

26.62

EPS (Unit Curr.)

3.99

5.34

9.6

20.69

5.48

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

50

75

120

15

Equity

12.03

11.32

11.32

11.02

9.71

Public Shareholding (Number)

3,63,80,990

3,28,61,152

3,25,61,152

3,25,72,716

2,59,02,644

Public Shareholding (%)

60.51

58.02

57.5

59.09

53.36

Pledged/Encumbered - No. of Shares

31,18,296

66,88,000

38,69,571

66,98,600

53,58,600

Pledged/Encumbered - % in Total Promoters Holding

13.13

28.13

16.07

29.7

23.67

Pledged/Encumbered - % in Total Equity

5.19

11.81

6.82

12.14

11.03

Non Encumbered - No. of Shares

2,06,24,566

1,70,74,700

2,01,93,128

1,58,52,535

1,72,83,660

Non Encumbered - % in Total Promoters Holding

86.87

71.86

83.91

70.3

76.33

Non Encumbered - % in Total Equity

34.3

30.15

35.66

28.76

35.59

PBIDTM(%)

10.35

10.69

12.48

16.15

11.81

PBDTM(%)

6.16

7.11

10

11.84

7.73

PATM(%)

1.9

2.61

5.15

9.9

3.36